This year's headlines on respiratory syncytial virus (RSV) focused largely on the relatively new vaccines -- including a new ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

But with respiratory syncytial virus, or RSV, how old you are can affect how sick you get. “Respiratory syncytial virus does present differently in folks of different ages,” says Kisha Davis ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

In a news release, Moderna said it expects the RSV vaccine – called mRESVIA – to be available in early 2025. There are two ...

(Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

This respiratory season, Essentia Health is excited to offer immunization options for respiratory syncytial virus (RSV) for both children and adults.